GR81952B - - Google Patents

Info

Publication number
GR81952B
GR81952B GR74163A GR840174163A GR81952B GR 81952 B GR81952 B GR 81952B GR 74163 A GR74163 A GR 74163A GR 840174163 A GR840174163 A GR 840174163A GR 81952 B GR81952 B GR 81952B
Authority
GR
Greece
Application number
GR74163A
Inventor
Ronald Vander-Mallie
Original Assignee
New England Nuclear Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Nuclear Corp filed Critical New England Nuclear Corp
Publication of GR81952B publication Critical patent/GR81952B/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/965—Chemistry: molecular biology and microbiology involving idiotype or anti-idiotype antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/966—Chemistry: molecular biology and microbiology involving an enzyme system with high turnover rate or complement magnified assay, e.g. multi-enzyme systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/819—Multifunctional antigen or antibody
GR74163A 1983-03-22 1984-03-21 GR81952B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/477,611 US4536479A (en) 1983-03-22 1983-03-22 Use of anti-idiotype antibodies in immunoassays

Publications (1)

Publication Number Publication Date
GR81952B true GR81952B (el) 1984-12-12

Family

ID=23896642

Family Applications (1)

Application Number Title Priority Date Filing Date
GR74163A GR81952B (el) 1983-03-22 1984-03-21

Country Status (6)

Country Link
US (1) US4536479A (el)
EP (1) EP0119629A3 (el)
JP (1) JPS59180362A (el)
CA (1) CA1225590A (el)
DK (1) DK164084A (el)
GR (1) GR81952B (el)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219730A (en) * 1982-09-28 1993-06-15 New York University Idiotype-anti-idiotype immunoassay
GB8317124D0 (en) * 1983-06-23 1983-07-27 Ekins R P Free ligand assay
US4828981A (en) * 1983-08-24 1989-05-09 Synbiotics Corporation Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
US5053224A (en) * 1983-11-07 1991-10-01 Hilary Koprowski Induction of antibody response to solid tumors with anti-idiotype antibodies
US4731237A (en) * 1983-11-07 1988-03-15 The Wistar Institute Immune response to virus induced by anti-idiotype antibodies
US5068177A (en) * 1983-12-28 1991-11-26 Scripps Clinic And Research Foundation Anti-idiotype antibodies induced by synthetic polypeptides
EP0161404B1 (de) * 1984-05-09 1990-09-26 Theurer, Karl Eugen, Prof.Dr.med. Verfahren zur Herstellung von künstlichen biomimetischen Haptenen bzw. Antigenen
US4683295A (en) * 1984-05-24 1987-07-28 Scripps Clinic And Research Foundation Method for the preparation of anti-receptor antibodies
EP0170302A1 (fr) * 1984-06-27 1986-02-05 l'Association internationale à but scientifique, dite: Institut international de pathologie cellulaire et moléculaire Procédé de dosage immunologique d'une substance dans un échantillon liquide au moyen d'anticorps anti-idiotypiques
US5144010A (en) * 1984-08-27 1992-09-01 The Trustees Of Columbia University In The City Of New York Method of producing monoclonal auto-anti-idiotypic antibodies
US4699880A (en) * 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
US4707443A (en) * 1985-04-19 1987-11-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same
US4689400A (en) * 1985-06-27 1987-08-25 The United States Of America As Represented By The Secretary Of The Navy Enhancement of specific antibody production with anti-IgD antibodies
US4818684A (en) * 1985-09-10 1989-04-04 The Trustees Of Columbia University In The City Of New York Auto-anti-idiotypic monoclonal antibodies to steroid receptors and uses thereof
US4777128A (en) * 1986-05-27 1988-10-11 Ethigen Corporation Fluorescence immunoassay involving energy transfer between two fluorophores
US5223441A (en) 1986-10-09 1993-06-29 Syntex (U.S.A.) Inc. Receptors for immune complexes
EP0302109A1 (en) * 1987-02-17 1989-02-08 LEWIS, Donald G. Liposomal immunoassay for antigens and for antigen specific immunoglobulins
US5260373A (en) * 1987-03-13 1993-11-09 Repligen Corporation Immobilized immunoglobulin-binding proteins
US6812024B2 (en) * 1987-03-16 2004-11-02 Mcgready Roland Keith Anti-paratopic antibody as an immunogen
EP0286405A3 (en) * 1987-04-08 1989-08-09 Synbiotics Corporation Method for the early selection of anti-idiotype-antibody internal images
JPH03501161A (ja) * 1987-08-07 1991-03-14 ゾーマ・コーポレーション 抗原決定基を模倣する方法並びに組成物
AU607533B2 (en) * 1987-08-07 1991-03-07 Xoma Corporation Methods and compositions for mimicking antigenic determinants
JPS6468398A (en) * 1987-09-08 1989-03-14 Agency Ind Science Techn Monoclonal anti-idiotype antibody and hybridoma and use thereof
US5212085A (en) * 1987-12-09 1993-05-18 The General Hospital Corporation Sf-25 colon adenocarcinoma antigen, and antibodies with recognize this antigen
DE3854999T2 (de) * 1987-12-09 1996-11-14 Gen Hospital Corp An karzinoma assoziierte antigene und antikörper, die diese antigene erkennen
US5449760A (en) * 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
WO1989009393A1 (en) * 1988-03-24 1989-10-05 Igen, Inc. Luminescent chimeric proteins
WO1989011296A1 (en) * 1988-05-17 1989-11-30 Raychaudhuri, Syamal Anti-idiotype antibodies to anti-human high molecular weight-melanoma associated antigen
US5162504A (en) * 1988-06-03 1992-11-10 Cytogen Corporation Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
US5645998A (en) * 1988-12-13 1997-07-08 University Of Florida Research Foundation Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
US6001360A (en) * 1988-12-13 1999-12-14 University Of Florida Method and compositions for early detection and treatment of insulin dependent diabetes mellitus
US5124249A (en) * 1989-11-28 1992-06-23 Khan Rashid H Method for evaluating protection to bee venom
EP0524249B1 (en) * 1990-04-06 1998-09-16 The University Of Florida Liquid-phase immunodiagnostic assay
GB9007966D0 (en) * 1990-04-09 1990-06-06 Dynal As Antigen/anti-antigen cleavage
AP237A (en) * 1990-05-29 1993-04-29 Cedars Sinai Medical Center Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use.
US5798251A (en) * 1990-05-29 1998-08-25 Cedars-Sinai Medical Center Antibody and antibody derivative immunoreagents reactive with a conserved epitope of Human Immunodeficiency Virus Type 1 (HIV-1) gp 120
DE4129849A1 (de) * 1991-02-14 1992-08-27 Boehringer Mannheim Gmbh Monoklonale antikoerper gegen humane pankreas-inselzellen
US5264556A (en) * 1991-04-18 1993-11-23 Rougier Inc. Monoclonal antibodies for measuring okadaic acid
DE4130786A1 (de) * 1991-09-16 1993-03-18 Symbiotec Gmbh Peptide zur herstellung von mitteln zur diagnose und therapie von systemischen lupus
AU3439693A (en) * 1992-01-22 1993-09-01 Abbott Laboratories Calibration reagents for semi-quantitative binding assays and devices
US20030144473A1 (en) * 1992-09-16 2003-07-31 Michael Zeppezauer Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases
US5756301A (en) * 1993-03-03 1998-05-26 The Trustees Of Columbia University In The City Of New York Endogenous taxol-like substance in human serum, monoclonal antibodies directed thereto and methods of assaying therefor
WO1998008090A1 (en) * 1995-06-06 1998-02-26 Epigen, Inc. Anti-idiotypic antibodies to an epiglycanin
WO2000011446A2 (en) * 1998-08-21 2000-03-02 University Of Virginia Patent Foundation Signal generating oligonucleotide-based biosensor
US6620909B1 (en) * 1999-04-20 2003-09-16 Zymogenetics, Inc. Adipocyte complement related protein homolog zacrp2
US20030031627A1 (en) * 2001-07-31 2003-02-13 Mallinckrodt Inc. Internal image antibodies for optical imaging and therapy
US7935539B2 (en) * 2003-02-14 2011-05-03 Siemens Healthcare Diagnostics, Inc. Generic method for latex agglutination assays
US20080206782A1 (en) * 2005-03-08 2008-08-28 Genentech, Inc. Methods for Determining the Bivalency of Protein and Antibody Therapeutics
EP1801594A1 (en) * 2005-12-23 2007-06-27 Koninklijke Philips Electronics N.V. Sensing device and method for determination of the amount of target molecule in an analyte
KR20140138971A (ko) * 2012-03-28 2014-12-04 제넨테크, 인크. 항-hcmv 이디오타입 항체 및 이들의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199559A (en) * 1974-08-12 1980-04-22 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4048298A (en) * 1975-02-25 1977-09-13 Rohm And Haas Company Solid phase double-antibody radioimmunoassay procedure
US4233402A (en) * 1978-04-05 1980-11-11 Syva Company Reagents and method employing channeling
US4401765A (en) * 1981-09-01 1983-08-30 E. I. Du Pont De Nemours And Company Covalently bonded high refractive index particle reagents and their use in light scattering immunoassays
ZA837119B (en) * 1982-10-07 1984-12-24 Amersham Int Plc Assay for the free portion of substances in biological fluids
US4692416A (en) * 1982-12-03 1987-09-08 Yeshiva University Monoclonal antibodies reactive with shared idiotypes on human antibodies to native DNA from patients with systemic lupus erythematosus

Also Published As

Publication number Publication date
DK164084D0 (da) 1984-03-22
US4536479A (en) 1985-08-20
JPS59180362A (ja) 1984-10-13
CA1225590A (en) 1987-08-18
EP0119629A2 (en) 1984-09-26
DK164084A (da) 1984-09-23
EP0119629A3 (en) 1986-12-30

Similar Documents

Publication Publication Date Title
GR81952B (el)
DE3331203C2 (el)
DE3316110C2 (el)
DE8421114U1 (el)
FR2545843B1 (el)
DE3314417C2 (el)
DE3341360C2 (el)
DE8407294U1 (el)
DE3308960C2 (el)
FR2540403B3 (el)
DE8324892U1 (el)
DE8324379U1 (el)
DE8311500U1 (el)
DE8331720U1 (el)
DE8322352U1 (el)
DE8300319U1 (el)
GR71435B (el)
DE8301424U1 (el)
DE8319447U1 (el)
GR71272B (el)
GR71470B (el)
GR71969B (el)
BG44913A1 (el)
BG44882A1 (el)
BG45249A1 (el)